Belite Bio CFO acquires 5,000 shares as stock grant vests

The CFO reported 180,264 directly held ordinary shares and a separate 30,000-share position through ESHJ Ltd.

Rhea-AI Filing Summary

Belite Bio, Inc. CFO Hao-Yuan Chuang reported vesting of 5,000 ordinary shares on October 29, 2026, after certain performance criteria were met for RSUs granted on September 15, 2025. His reported direct holdings following the transaction were 180,264 ordinary shares. He also reported 30,000 ordinary shares held indirectly through ESHJ Ltd., a company wholly beneficially owned by him; those shares had been transferred to ESHJ Ltd. on June 8, 2026.

Insider Trade Summary

Other: 5,000 shares

Other 2 txns

Insider Chuang Hao-Yuan

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Other	Ordinary Share F1, F2	5,000	$0.00	$0.00
holding	Ordinary Share	--	--	--

Holdings After Transaction: Ordinary Share — 180,264 shares (Direct); Ordinary Share — 30,000 shares (Indirect, By ESHJ Ltd)

Footnotes (2)

1. F1. On September 15, 2025, the reporting person was granted an award of restricted stock units ("RSUs") which shall vest upon satisfaction of several performance criteria. Certain of these performance criteria were met on 10/29/2026, resulting in vesting of the RSUs as to 5,000 ordinary shares.
2. F2. Excludes 30,000 ordinary shares previously reported as directly owned, which the reporting person transferred on June 8, 2026 to ESHJ Ltd, a company wholly beneficially owned by the reporting person.

Key Figures

RSU-vested ordinary shares: 5,000 shares Direct ordinary shares following transaction: 180,264 shares Indirect ordinary shares through ESHJ Ltd.: 30,000 shares +2 more

5 metrics

RSU-vested ordinary shares 5,000 shares Vested October 29, 2026

Direct ordinary shares following transaction 180,264 shares Reported after the October 29, 2026 transaction

Indirect ordinary shares through ESHJ Ltd. 30,000 shares Reported as held indirectly

RSU award date September 15, 2025 Date the RSUs were granted

Transfer date June 8, 2026 Date the 30,000 ordinary shares were transferred to ESHJ Ltd.

Key Terms

restricted stock units, performance criteria, vesting, beneficially owned

4 terms

restricted stock units financial

"award of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

performance criteria financial

"satisfaction of several performance criteria"

vesting financial

"resulting in vesting of the RSUs"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

beneficially owned regulatory

"company wholly beneficially owned by the reporting person"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BLTE shares did CFO Hao-Yuan Chuang receive from RSU vesting?

Hao-Yuan Chuang, Belite Bio's Chief Financial Officer, had 5,000 ordinary shares vest on October 29, 2026, after certain performance criteria were met for RSUs granted on September 15, 2025.

What were Hao-Yuan Chuang's reported BLTE share holdings after the transaction?

He reported 180,264 ordinary shares held directly following the transaction, along with 30,000 ordinary shares held indirectly through ESHJ Ltd., a company wholly beneficially owned by him.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/30/2026 - 09:00 PM EDT Accepted by SEC EDGAR 10/30/2026 - 09:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chuang Hao-Yuan

(Last) (First) (Middle)

12750 HIGH BLUFF DRIVE, SUITE 475

(Street)

SAN DIEGO CALIFORNIA 92130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BELITE BIO, INC [ BLTE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Share	10/29/2026		J(1)		5,000(1)	A	$0(1)	180,264(2)	D
Ordinary Share								30,000	I	By ESHJ Ltd

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On September 15, 2025, the reporting person was granted an award of restricted stock units ("RSUs") which shall vest upon satisfaction of several performance criteria. Certain of these performance criteria were met on 10/29/2026, resulting in vesting of the RSUs as to 5,000 ordinary shares.

2. Excludes 30,000 ordinary shares previously reported as directly owned, which the reporting person transferred on June 8, 2026 to ESHJ Ltd, a company wholly beneficially owned by the reporting person.

	/s/ Hao-Yuan Chuang	10/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)